Doskaliuk, B. Et Al. 2023. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology International , vol.43, no.9 , 1651-1664.

Doskaliuk, B., Ravichandran, N., Sen, P., Day, J., Joshi, M., Nune, A., ... Nikiphorou, E.(2023). Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology International , vol.43, no.9, 1651-1664.

Doskaliuk, Bohdana Et Al. "Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study," Rheumatology International , vol.43, no.9, 1651-1664, 2023

Doskaliuk, Bohdana Et Al. "Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study." Rheumatology International , vol.43, no.9, pp.1651-1664, 2023

Doskaliuk, B. Et Al. (2023) . "Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study." Rheumatology International , vol.43, no.9, pp.1651-1664.

@article{article, author={Bohdana Doskaliuk Et Al. }, title={Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study}, journal={Rheumatology International}, year=2023, pages={1651-1664} }